Caseware UK (AP4) 2024.0.164 2024.0.164 2024-04-302024-04-30trueNo description of principal activity22023-04-24truefalse 14823102 2023-04-23 14823102 2023-04-24 2024-04-30 14823102 2022-04-24 2023-04-23 14823102 2024-04-30 14823102 c:Director1 2023-04-24 2024-04-30 14823102 c:EntityHasNeverTraded 2023-04-24 2024-04-30 14823102 c:Micro-entities 2023-04-24 2024-04-30 14823102 c:AuditExempt-NoAccountantsReport 2023-04-24 2024-04-30 14823102 c:FullAccounts 2023-04-24 2024-04-30 14823102 c:PrivateLimitedCompanyLtd 2023-04-24 2024-04-30 14823102 d:PoundSterling 2023-04-24 2024-04-30 iso4217:GBP xbrli:pure

Registered number: 14823102









GENESIS GP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 30 APRIL 2024

 
GENESIS GP LIMITED
REGISTERED NUMBER: 14823102

BALANCE SHEET
AS AT 30 APRIL 2024

2024
£


Called up share capital not paid
80

Total assets less current liabilities
80


Net assets
80



Capital and reserves
80


Notes


General information

Genesis GP Limited is a private company, limited by shares, registered in England and Wales. The address of the company's registered office is Ground Floor, 45 Pall Mall, London, SW1Y 5JG. 


Average number of employees

The average monthly number of employees, including directors, during the period was 2.

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
J H Sealey
Director

Date: 9 January 2025

Page 1